Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nanaka Katsurayama
Observed names:
Katsurayama Nanaka,
N. Katsurayama,
NANAKA KATSURAYAMA
Institutions:
Tokyo Women's Medical University Adachi Medical Center,
Tokyo Women's Medical University
Observed institutions:
Tokyo Women's Medical University Hospital,
Tokyo Women's Medical University Adachi Medical Center,
Tokyo Women's Medical University
ORCID:
0009-0001-0439-8875
Observed ORCID:
0009-0001-0439-8875
OpenAlex ID:
A5099846768
Comparison of real-world outcomes between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib combination therapies for previously untreated advanced renal cell carcinoma
2025
·
Hiroki Ishihara
, Kenji Omae
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
9
Prognostic Impact of the Administration of Antibiotics and Proton Pump Inhibitors in Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma
2024
·
NANAKA KATSURAYAMA
, HIROKI ISHIHARA
, et al.
·
Cancer Diagnosis & Prognosis
·
6
PDF
Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR ‐ TKIs in Real‐World Patients With Advanced Renal Cell Carcinoma
2026
·
Hiroki Ishihara
, Nanaka Katsurayama
, et al.
·
International Journal of Urology
·
5
PDF
Prognostic impact of lenvatinib dose intensity in previously untreated patients with advanced renal cell carcinoma receiving lenvatinib plus pembrolizumab
2026
·
Koichi Nishimura
, Hiroki Ishihara
, et al.
·
Japanese Journal of Clinical Oncology
·
2
Effectiveness and Safety of Enfortumab Vedotin Plus Pembrolizumab for Patients Aged 80 Years and Older With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study
2026
·
YUKI KOBARI
, NAO NAKAJIMA
, et al.
·
Anticancer Research
·
1
Real-World Outcomes of Adjuvant Pembrolizumab for Renal Cell Carcinoma: The Potential Role of PD-L1 as a Prognostic Biomarker
2026
·
Hiroki Ishihara
, Takayuki Nakayama
, et al.
·
Targeted Oncology
·
1
PDF
Ip83-04 Increased Risk of Interstitial Lung Disease With Enfortumab Vedotin Plus Pembrolizumab Compared With Sequential Enfortumab Vedotin in Metastatic Urothelial Carcinoma: a Multicenter Retrospective Study in Japan
2026
·
Yuki Kobari
, Junpei Iizuka
, et al.
·
The Journal of Urology
·
1
PDF
Requiring Caution in the Interpretation of Donor‐Derived Cell‐Free DNA Levels During Cancer Treatment in a Kidney Transplant Recipient.: A Case Report
2026
·
Nanaka Katsurayama
, Toshihito Hirai
, et al.
·
IJU Case Reports
·
1
A Case of Complete Remission of Bilateral Upper Tract Carcinoma In Situ Following Retrograde Bacillus Calmette–Guérin ( BCG ) Instillation via Open‐Ended Ureteral Catheters After Failure Using Double‐J Stents
2025
·
Nanaka Katsurayama
, Toshihide Horiuchi
, et al.
·
IJU Case Reports
·
1
PDF
High real-world incidence of hepatic dysfunction from cabozantinib plus nivolumab for Japanese patients with metastatic renal cell carcinoma
2025
·
Toshihide Horiuchi
, Koichi Nishimura
, et al.
·
Japanese Journal of Clinical Oncology
·
1
Real-world incidence of interstitial lung disease with enfortumab vedotin plus pembrolizumab or enfortumab vedotin monotherapy in metastatic urothelial carcinoma: a multicenter retrospective study in Japan
2026
·
Yuki Kobari
, Nao Nakajima
, et al.
·
Japanese Journal of Clinical Oncology
Ip78-15 Prognostic Impact of Early C-reactive Protein Dynamics in Advanced Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitor Combinations
2026
·
Koichi Nishimura
, Hiroki Ishihara
, et al.
·
The Journal of Urology
PDF
Outcomes of tyrosine kinase inhibitor monotherapy for advanced renal cell carcinoma arising in patients with kidney transplantation: comparison with sporadic and end-stage renal disease populations
2025
·
Nanaka Katsurayama
, Hiroki Ishihara
, et al.
·
Clinical and Experimental Nephrology
Relative Changes in Donor-Derived Cell-Free DNA as a Marker of Allograft Rejection in a Kidney Transplant Recipient with Metastatic Cancer Undergoing Immunotherapy
2025
·
N. Katsurayama
, T. Hirai
, et al.
·
American Journal of Transplantation
Ip17-15 Gene Profile of Old Donor Kidney Related to Kidney Function Before and After Kidney Transplantation
2025
·
Toshihito Hirai
, Rikako Oki
, et al.
·
The Journal of Urology
PDF
Effectiveness of Robot-assisted Adrenalectomy for a Giant Adrenal Hemangioma: A Case Report
2024
·
NANAKA KATSURAYAMA
, YUKI KOBARI
, et al.
·
In Vivo
PDF
Show more works
View as search
Works count:
16
Citation count:
28
H-index:
3
I10-index:
Year
Topic
Type